APL-1202 and APL-1501 (Single ascending dose)
YHGT-PN-02
Phase 1 small_molecule active
Quick answer
APL-1202 and APL-1501 (Single ascending dose) for Bladder Cancer is a Phase 1 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jian Li
- Indication
- Bladder Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active